Robert Califf, FDA commissioner (Michael Brochstein/Sipa USA/Sipa via AP Images)
April 21, 2022 01:34 PM EDTUpdated April 22, 04:59 PM
FDA+
Coronavirus

Biotech, aca­d­e­m­ic lead­ers en­cour­age FDA to con­sid­er T-cell as­sess­ment in Covid-19 vac­cine tri­als

Tyler Patchen

News Reporter

More than 60 sig­na­to­ries sent a let­ter to the FDA’s Robert Califf and Pe­ter Marks on Thurs­day urg­ing the agency to in­clude a rec­om­men­da­tion for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times